用于诊断和治疗的分子打印载体-一个批判性的评估
Emilia Balcer1, Monika Sobiech2, Piotr Luliński2
1Department of Drug Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
Pharmaceutics
|June 28, 2023
概括
分子印记聚合物 (MIPs) 显示了光学的巨大潜力,通过向药物输送和诊断实现了个性化医疗. 它们独特的特性使得它们非常适合用于先进的医疗应用.
科学领域:
- 聚合物科学 聚合物科学
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 综合诊断和治疗的治疗学是个性化医学的关键趋势.
- 有效的药物载体对于超神应用至关重要.
- 分子印记聚合物 (MIP) 是药物载体的有希望的材料,因为它们的稳定性和特异性.
研究的目的:
- 审查MIPs在theranostics中的应用.
- 讨论MIP与诊断和治疗相关的特性.
- 探索MIP构建策略的目标和预测方法.
主要方法:
- 关于MIPs和theranostics的当前文献的审查.
- 分子印记技术的特征.
- 讨论用于诊断和治疗应用的MIP合成策略.
主要成果:
- MIP提供化学和热稳定性,集成能力和高特异性.
- 在制备过程中通过模板分子的存在来实现MIP特异性.
- 可以设计MIP以针对药物输送和生物成像.
结论:
- MIP是多功能材料,在天文学领域具有显著的潜力.
- 进一步开发MIP对于推进个性化医学的发展至关重要.
- 未来的研究应该专注于优化MIP设计,以满足特定的异能应用.
更多相关视频
08:22Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
12.1K
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.7K
相关概念视频
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
